Melatonin Ameliorates Doxorubicin-induced Skin Necrosis in Rats

Abstract

Doxorubicin (DXR), a highly effective chemotherapeutic agent, causes serious injury when extravasated. The injury can sometimes result in skin necrosis and ulceration, requiring surgery. The detrimental effect of DXR on the antioxidant system via free oxygen radicals is one of the mechanisms proposed in its etiology. Thus, we used melatonin, a potent antioxidant, and compared the effects with dimethylsulfoxide (DMSO), which is used in the treatment of patients with DXR-induced extravasation.Twenty-seven Wistar-albino rats were used. After intradermal injection of DXR, DMSO was injected into the extravasated area and melatonin was given intraperitoneally. On day 14 of the experiment, skin ulcers were clearly formed and samples were taken with a punch biopsy. Ulcer sizes were measured. Tissue samples were analyzed for superoxide dismutase, glutathione peroxidase, and malondialdehyde enzymes, and histopathologically evaluated.Melatonin clearly decreased MDA levels, ulcer size, and histopathologic ulcer scores in DXR extravasated tissue. DMSO also decreased MDA levels, ulcer size and histopathologic ulcer score. However, melatonin was remarkably more effective than DMSO in terms of antioxidant enzyme activity, oxidative stress, and histopathologic ulcer scores in rats. Necrosis was evident in the DXR-treated group and some slides showed necrosis involving the fascia. Histopathologic ulcer scores of the necrotic tissue decreased in the DMSO and melatonin groups. The ulcer score in the melatonin group was significantly lower than in the control group. Although the ulcer score in the DMSO group was lower than control, there was no statistically significant difference. The ulcer size in the DMSO group was significantly lower than the control group. The ulcer size in the melatonin group was significantly lower than both the DMSO and control groups.We believe that melatonin, either alone or in combination with DMSO, may be used for treating DXR extravasation. In addition, free oxygen radicals play a crucial role in the etiology of the injury, which should be considered in further studies.

Utilizing Melatonin to Alleviate Side Effects of Chemotherapy: A Potentially Good Partner for Treating Cancer with Ageing

“…Oxidative Medicine and Cellular Longevity [22,99]. Melatonin administered in parallel with DNR reduced the proportion of apoptotic cardiomyocytes [100].…”

Melatonin reduces proliferation and promotes apoptosis of bladder cancer cells by suppressing O‐GlcNAcylation of cyclin‐dependent‐like kinase 5

“…On the basis of its anti‐proliferative and pro‐apoptotic effects, melatonin suppresses the growth of certain types of cancer. It can promote apoptosis by regulating expression of Bcl‐2, caspase‐3, and caspase‐9, inhibit tumor cell proliferation through the PI3K/AKT pathway, 3 and suppress metastasis‐related molecular processes by restricting entry of cancer cells into the vascular system and preventing them from forming secondary growth in distant areas 4,5 . In combination treatments with anticancer drugs such as sorafenib and doxorubicin, melatonin displayed strong anticancer effects in in vitro and in vivo 6 …”

Ozone Ameliorates Doxorubicine-Induced Skin Necrosis - results from an animal model

“…Ozone has been known to induce a type of cross tolerance to free radicals released after an ischemia-reperfusion injury 14,15 and to increase antioxidant enzyme activities, such as GPx, SOD, and catalase, which prepares the host ready for physiopathological conditions mediated by reactive oxygen species in experimental studies. 16 The levels of catalase, SOD, and GPx increase as a protective response to chronic ozone exposure in animals and plants. Ozone can also balance the intracellular calcium level that increases because of the inhibition of CaATPase activity during oxidative stress and can play a very important role in oxidative stress–induced cell damage and death.…”